Serum Amyloid A1 (SAA1) antibody and antigen (Recombinant protein)
Diagnostic Serum Amyloid A1 (SAA1) antibodies (anti-Serum Amyloid A1, anti-SAA1) and antigens (recombinant Serum Amyloid A1 (SAA1) protein) for Inflammation/autoimmune/inflammatory disease SAA1 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-SAA1-Ag01 | Recombinant human SAA1 Protein | 3090 |
GMP-h-SAA1-Ab01 | Anti-human SAA1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-SAA1-Ab02 | Anti-human SAA1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-SAA1-Ab03 | Anti-human SAA1 human monoclonal antibody (mAb) | 1953 |
GMP-h-SAA1-Ab04 | Anti-human SAA1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-SAA1-Ag01 |
Product Name | Recombinant human SAA1 Protein |
Target/Biomarker | Serum Amyloid A1(SAA1) |
Alias of Target/Biomarker | PIG4, SAA, SAA2, TP53I4 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Serum Amyloid A1 (SAA1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in SAA1 level test of Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) and related syndrome evaluation. |
Products description | Recombinant human SAA1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-SAA1-Ab01, GMP-h-SAA1-Ab02 |
Product Name | Anti-human SAA1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Serum Amyloid A1(SAA1) |
Alias of Target/Biomarker | PIG4, SAA, SAA2, TP53I4 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Serum Amyloid A1 (SAA1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Serum Amyloid A1 (SAA1) antibodies in SAA1 level test of Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human SAA1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-SAA1-Ab03, GMP-h-SAA1-Ab04 |
Product Name | Anti-human SAA1 human monoclonal antibody (mAb) |
Target/Biomarker | Serum Amyloid A1(SAA1) |
Alias of Target/Biomarker | PIG4, SAA, SAA2, TP53I4 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human Serum Amyloid A1 (SAA1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Serum Amyloid A1 (SAA1) antibodies in SAA1 level test of Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human SAA1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Serum amyloid A1 is made primarily in the liver and circulates in low levels in the blood. Serum amyloid A1 appears to play a role in the immune system. Serum amyloid A1 may help repair damaged tissues, act as an antibacterial agent, and signal the migration of germ-fighting cells to sites of infection. Levels of this protein increase in the blood and other tissues under conditions of inflammation. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. SAA1 has been a clinical indicator and reliable biomarker for inflammatory diseases, chronic metabolic disorders and late-stage malignancy. Inflammatory amyloidosis results from chronic inflammation with increased production of SAA1, which is a major precursor of amyloid A fibril deposit in various tissues.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments